Morning Briefing
Summaries of health policy coverage from major news organizations
AI Shows Promise In Tracking Depression Recovery, Heart Health Risks
Stat: How AI Helped Researchers Track Recovery From Depression
Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say. (Ravindranath, 9/20)
CBS News: AI Is Helping Doctors Measure Cardiovascular Risks
Artificial intelligence is being used to help doctors better diagnose a number of health conditions. Now, it's showing views of the heart like nothing they've seen before, providing doctors with the ability to predict if someone is going to have a heart attack or develop cardiovascular disease. ... "The artificial intelligence program that we're utilizing looks at plaque and it breaks it down into the types of plaque, because some types of plaque are more dangerous than others," said cardiologist, Dr. Richard Chazal. (Stahl, 9/20)
Bloomberg: Google DeepMind's AI Tool Could Pinpoint Our Genetic Faults
It’s becoming increasingly clear that scientists are only scratching the surface of what artificial intelligence can teach us about human biology and disease. Case in point: new work by Alphabet's AI subsidiary, Google DeepMind, that promises to help winnow down the genetic causes of disease. (Jarvis, 9/20)
CBS News: New Monell Center Research Teaches AI How To Smell
The science of smells has gone digital with a new research project from Philadelphia's Monell Chemical Senses Center. This research is using artificial intelligence to train computers to recognize certain smells, which could help various industries that depend on scents, as well as doctors with finding diseases. ... The technology being developed at the Monell Center could eventually be used to make electronic noses to detect things, like cancer. (Stahl, 9/20)
